Sigma

Sigma Broking extends partnership with ION to allow customers to route orders to the LME

Retrieved on: 
Wednesday, March 20, 2024

Sigma is an international, privately owned brokerage company servicing institutional customers and deploys ION's post-trade solutions to automate its middle- and back-office operations.

Key Points: 
  • Sigma is an international, privately owned brokerage company servicing institutional customers and deploys ION's post-trade solutions to automate its middle- and back-office operations.
  • Under the new agreement, Sigma will now also leverage the XTP Execution (XTP-E) suite to offer customers the capability to trade listed derivatives on the London Metal Exchange (LME).
  • ION is one of the premier software providers routing orders to the LME, providing automated services for retail and institutional firms worldwide.
  • Using XTP Execution, Sigma is able to capitalize on additional opportunities on the LME, using integrated workflows and connected data for real-time insights."

Sigma Broking extends partnership with ION to allow customers to route orders to the LME

Retrieved on: 
Wednesday, March 20, 2024

Sigma is an international, privately owned brokerage company servicing institutional customers and deploys ION's post-trade solutions to automate its middle- and back-office operations.

Key Points: 
  • Sigma is an international, privately owned brokerage company servicing institutional customers and deploys ION's post-trade solutions to automate its middle- and back-office operations.
  • Under the new agreement, Sigma will now also leverage the XTP Execution (XTP-E) suite to offer customers the capability to trade listed derivatives on the London Metal Exchange (LME).
  • ION is one of the premier software providers routing orders to the LME, providing automated services for retail and institutional firms worldwide.
  • Using XTP Execution, Sigma is able to capitalize on additional opportunities on the LME, using integrated workflows and connected data for real-time insights."

Knack Global Welcomes Jatin Malhotra as Chief Technology Officer

Retrieved on: 
Tuesday, March 12, 2024

CORAL SPRINGS, Fla., March 12, 2024 /PRNewswire-PRWeb/ -- Knack Global, a Florida-based industry-leading provider of end-to-end revenue cycle management ("RCM") solutions, is pleased to announce the appointment of Jatin Malhotra as its Chief Technology Officer (CTO). Knack has continued to strategically accelerate its investment in its automation and software development teams across the organization to build on its standing as a leading tech-enabled service provider and technology company. In this role, Jatin will drive Knack Global's technological and automation initiatives, furthering its commitment to delivering cutting-edge RCM solutions to clients across the US.

Key Points: 
  • New Technology Leadership Accelerates Investment in AI, Automation, and Technology Enablement
    CORAL SPRINGS, Fla., March 12, 2024 /PRNewswire-PRWeb/ -- Knack Global, a Florida-based industry-leading provider of end-to-end revenue cycle management ("RCM") solutions, is pleased to announce the appointment of Jatin Malhotra as its Chief Technology Officer (CTO).
  • Prior to joining Knack, Jatin served as the Chief Technology Officer at Jorie Healthcare Partners LLC, where he spearheaded the implementation of AI-based automation within revenue cycle management services, driving operational efficiency and client satisfaction.
  • "We are thrilled to welcome Jatin to the Knack team," said Rajiv Sharma, CEO at Knack.
  • "I am excited to join Knack Global and contribute to its mission of delivering transformative solutions to clients," said Jatin Malhotra.

NOBLIS MSD NAMES JIM BROADWATER AS VICE PRESIDENT OF ITS NAVSEA DIVISION

Retrieved on: 
Tuesday, March 5, 2024

Reston, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the Department of Defense, today named Jim Broadwater as vice president of its Naval Sea Systems Command (NAVSEA) division.

Key Points: 
  • Reston, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the Department of Defense, today named Jim Broadwater as vice president of its Naval Sea Systems Command (NAVSEA) division.
  • Reporting to Glenn Hickok , Noblis MSD president, Broadwater will expand the company’s NAVSEA strategy to bring additional digital engineering and breakthrough technologies to its U.S. Navy partners.
  • “Jim has deep domain knowledge and an unwavering commitment to innovation, operational excellence and fiscal responsibility,” said Hickok.
  • “Under his leadership, Noblis has delivered high-value transformational solutions and rapid prototypes that help our U.S. Navy partners advance mission readiness and competitive advantage.

Eldorado Announces 2024 Detailed Production & Cost Guidance; Provides Four-Year Growth Profile

Retrieved on: 
Thursday, February 22, 2024

Gold production in 2024 is expected to be between 505,000 to 555,000 ounces, a 9% increase from 2023 gold production (based on the mid-point of the range).

Key Points: 
  • Gold production in 2024 is expected to be between 505,000 to 555,000 ounces, a 9% increase from 2023 gold production (based on the mid-point of the range).
  • Exploration and evaluation expenses are expected to be $27 to $30 million in 2024, with 65% expensed, and 35% capitalized.
  • In 2024, production guidance of 175,000 to 190,000 ounces at the Lamaque Complex is consistent with the previously guided range of 180,000 to 190,000 ounces.
  • Gold production of 675,000 to 735,000 ounces by 2027, resulting in growth of 45% over the four-year period from 2023 production and a compound annual growth rate of over 9%.

VTS Announces Accelerate 2024, the Leading Innovation Conference for Commercial Real Estate Executives

Retrieved on: 
Tuesday, February 27, 2024

The premier conference will bring together more than 400 innovative executives and influential thought leaders to discuss the technologies, trends, and ideas that define modern real estate, as well as methods and tactics to best leverage intelligence to achieve success in today’s market.

Key Points: 
  • The premier conference will bring together more than 400 innovative executives and influential thought leaders to discuss the technologies, trends, and ideas that define modern real estate, as well as methods and tactics to best leverage intelligence to achieve success in today’s market.
  • Accelerate 2024 will be a one-day event, featuring content including keynote presentations from distinguished guest speakers and VTS executives, VTS user-education content, and networking events.
  • Attendees will leave Accelerate 2024 armed with actionable tactics to help their organizations best navigate current dynamics in the market and seize opportunities.
  • Accelerate also will provide the opportunity to interface with product pop-ups, live demos, and a technical genius bar.

Mercy Names Michael Englehart to Lead Cardiovascular Services

Retrieved on: 
Monday, March 4, 2024

ST. LOUIS, March 4, 2024 /PRNewswire/ -- Michael Englehart has been named president of cardiovascular services across Mercy, the final service line president announced in six specialty service areas.

Key Points: 
  • ST. LOUIS, March 4, 2024 /PRNewswire/ -- Michael Englehart has been named president of cardiovascular services across Mercy, the final service line president announced in six specialty service areas.
  • "We have been very deliberate about finding the best people to lead our specialty services across Mercy's large footprint, and Michael completes our team," said Dr. Jeff Ciaramita , Mercy president of specialty service lines.
  • "It's critical to have the right people leading these foundational services so we provide the best care possible.
  • I am eager to contribute to establishing a solid foundation for its continued success, specifically in cardiovascular services."

SIGMA LITHIUM IS AWARDED BY BNDES A LETTER OF INTENTION FOR DEVELOPMENT BANK DEBT TO FUND CONSTRUCTION OF ITS ENVIRONMENTALLY FULLY LICENSED SECOND GREENTECH INDUSTRIAL LITHIUM PLANT

Retrieved on: 
Monday, February 12, 2024

SÃO PAULO, Feb. 12, 2024 /PRNewswire/ -- Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML, BVMF: S2GM34, TSXV: SGML), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon neutral, socially and environmentally sustainable lithium concentrate, is pleased to announce that it received a Letter of Intention for a project finance credit line ("Development Bank Credit Line") from the Development Bank of the Brazil (the "BNDES"). The Development Bank Credit Line will be used for the expansion of the Company's world class unique Quintuple Zero Green Lithium Grota do Cirilo project in Vale do Jequitinhonha in Brazil (the "Project").

Key Points: 
  • Sigma Lithium completed the certification process with BNDES, which included the filing of the final FEL3 Capex for Construction and Engineering of the Second Greentech Plant totaling R$ 492,4 million or approximately US$ 100 million
    The Letter of Intention by BNDES outlines its intention to extend the Company development bank debt financing ("Development Bank Debt") to fund the Second Greentech industrial lithium concentrate production plant ("Second Greentech Plant") at Vale do Jequitinhonha in Brazil.
  • The Second Greentech Plant will introduce additional innovations that will further increase the efficiency of its industrial process to beneficiate spodumene ore into Quintuple Zero Green Lithium.
  • Ana Cabral-Gardner, CEO and Co-Chairman said: "We are honored and delighted with the Letter of Intention received today from BNDES.
  • Having BNDES as a creditor represents the support of the government of Brazil to Sigma Lithium's industrial expansion plans at Vale do Jequitinhonha."

Hobolite Announces Expansion into Korean Market with Saeki P&C

Retrieved on: 
Monday, February 5, 2024

SHANGHAI, Feb. 5, 2024 /PRNewswire/ -- Today marks a significant milestone for Hobolite, a leader in design-driven lighting technology, as we proudly announce our expansion into the South Korean market.

Key Points: 
  • SHANGHAI, Feb. 5, 2024 /PRNewswire/ -- Today marks a significant milestone for Hobolite, a leader in design-driven lighting technology, as we proudly announce our expansion into the South Korean market.
  • This synergy promises to enhance the creative capabilities of professionals and enthusiasts alike within the Korean market.
  • "Our expansion into the Korean market is a testament to ensuring that every artist, regardless of where they are, has access to lighting that enhances both their workspace and their creative process," said Helena Bian, CEO of Hobolite.
  • As we gear up for the launch of Hobolite in the Korean market, we are thrilled about the potential impact our advanced lighting solutions will have on the creative sector.

Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

Retrieved on: 
Tuesday, January 30, 2024

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, taking place February 5-8, 2024. The DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems that are looking to complement central hub laboratories by advancing the technology and capabilities of satellite and independent hospital laboratories.

Key Points: 
  • DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, taking place February 5-8, 2024.
  • The new DxC 500 AU Chemistry Analyzer advances capabilities of spoked labs with a broad menu of high-quality assays that deliver consistent, commutable results across Beckman Coulter's AU clinical chemistry systems, positively impacting clinical decision-making and patient outcomes."
  • The DxC 500 AU Chemistry Analyzer features advanced automation technology, onboard guided workflows, and standardized reagents for use across healthcare networks.
  • The DxC 500 AU Chemistry Analyzer is for in vitro diagnostic use only.